04:06 PM EST - Ambrilia Biopharma : on Friday posted a second quarter net loss of $3.12 million or $0.07 per common share, narrower than a net loss of $6.75 million orC$0.22 per common share in the prior year quarter. Revenues for the quarter were $3.71 million, compared to $0.20 million in the corresponding quarter last year. Ambrilia Biopharma
shares T.AMB are trading down 9 cents at $0.10.
